Receptor residence time trumps drug-likeness and oral bioavailability in determining efficacy of complement C5a antagonists.
- Published in:
- Scientific Reports, 2016, p. 24575, doi. 10.1038/srep24575
- By:
- Publication type:
- Article
Works by Cotterell, Adam J.
Results: 2
1
2
An antagonist of human protease activated receptor-2 attenuates PAR2 signaling, macrophage activation, mast cell degranulation, and collagen-induced arthritis in rats.
- Published in:
- FASEB Journal, 2012, v. 26, n. 7, p. 2877, doi. 10.1096/fj.11-201004
- By:
- Publication type:
- Article